Skip to research
Margin Monkey THEMARGINMONKEY Start my free trialTry free

Becton Dickinson (BDX) stock in plain English

Free brief · no signupStart here
BDXPublished Nov 13, 2026
Becton Dickinson & Co
Healthcare · Medical Instruments & Supplies
Manufactures medical devices, laboratory equipment, and diagnostic products used in healthcare settings.
Assets:
Manufacturing networkOperates dozens of production facilities across the Americas, Europe, and Asia.
Global workforceEmploys over 70,000 people across medical, life sciences, and interventional units.
High-volume consumablesProduces billions of needles, syringes, and sample collection tubes annually.
Locked assetIn the full report
Rated Nov 19, 2026

Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.

42
OPS ScoreOperating finances
Latest quote
-1.57%$212.68
$57.93B
51.4×
$20.26B

Change shown by the quote provider. Data may be delayed.

Financial statements, in plain wordsSales, profit, debt and cash, year by year
Published Nov 13, 2026Quotes updated Nov 20, 04:05 UTCOPS Score, TMM Score and the rating are research summaries, not advice or forecasts.
That was BDX. The desk has 1,900+ more companies.Each one comes with its scores, its flags and the sources behind them.
7 days free · No card

What does Becton Dickinson (BDX) do?

Becton Dickinson & Co (BDX) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Manufactures medical devices, laboratory equipment, and diagnostic products used in healthcare settings. It produces massive volumes of essential medical consumables like syringes, needles, and diagnostic tubes used globally. It is worth $57.93B on the market and sold $20.26B over the last year.

Market cap
$57.93B
P/E ratio
51.4×
Annual sales
$20.26B
Sector
Healthcare
Industry
Medical Instruments & Supplies
Brief updated
Nov 13, 2026

Brands and businesses behind BDX

  • BD Vacutainer: Manufactures blood collection tubes and needles, generating revenue through recurring consumable sales to clinical laboratories worldwide.
  • BD Pyxis: Sells automated medication and supply management systems to hospitals through equipment sales and recurring maintenance contracts.
  • BD Alaris: Provides hospital infusion pump systems and generates money from hardware sales, dedicated disposable sets, and software upgrades.
  • PureWick: Offers noninvasive urine collection systems, earning revenue through ongoing direct-to-consumer and hospital supply sales.
  • BD FACSCanto: Builds clinical flow cytometry systems, earning revenue from device installations, calibration services, and specialized reagent kits.

BDX’s flags, in plain English

Each flag is a number from Becton Dickinson’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 13, 2026.

Wide Gross Margin

Gross margin of 56% after the cost of making its products. There is a large gap between what its products cost to make and what they sell for, and that gap pays for everything else.

Pays You to Hold

Pays a 1.93% dividend a year. The company pays part of its profit to shareholders in cash. A dividend can be cut, so it is not guaranteed.

Runway Is Short

This year's bills are bigger than the cash and assets on hand to pay them. At its current rate of spending, its cash on hand covers only a limited stretch.

2 more risk notes open with the free trial. Try it free for 7 days.

Questions about BDX

How big is Becton Dickinson?

Becton Dickinson’s market cap is $57.93B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $20.26B: what customers paid the company over the last year, before any costs.

What is BDX’s P/E ratio?

BDX’s P/E ratio is 51.4×. Investors pay about 51.4 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.

What could go wrong with BDX?

The company carries over fifteen billion dollars in long-term debt following major historical acquisitions. That is one risk on Becton Dickinson’s card. Its first risk flag is Runway Is Short, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.

Where do these numbers come from?

From Becton Dickinson’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. BDX’s filings on SEC.gov. The Margin Monkey is research, not advice.

Your first 7 days are free.Search all 1,900+ companies and open every card. Members also get the ratings, Picks and the TMM Score.
7 days free · No card